Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2588)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2021 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen X, Zhao F, Pan WJ, Di JM, Xie WN, Yuan L, Liu Z. Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits. World J Clin Cases 2021; 9(33): 10172-10179 [PMID: 34904087 DOI: 10.12998/wjcc.v9.i33.10172] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i33/10172.htm |
| Number | Citing Articles |
| 1 |
Lei Yan, Qiuyue Xiong, Qin Xu, Pengru Ren, Tiantian Li, Huixia Cao, Fengmin Shao. Study on the correlation between mineral bone metabolism and CRP in patients with SHPT during perioperative period. Immunity, Inflammation and Disease 2023; 11(4) doi: 10.1002/iid3.828
|
| 2 |
L. V. Egshatyan. Selective vitamin D receptor activator Paricalcitol and its potential benefits in hemodialysis patients with secondary hyperparathyroidism. Meditsinskiy sovet = Medical Council 2022; (10): 132 doi: 10.21518/2079-701X-2022-16-10-132-139
|